How does this study impact current management guidelines? A history of respiratory reactions on alcohol ingestion may aid in the suspicion of aspirin exacerbated respiratory disease; clinicians should warn their patients about this possibility.
BACKGROUND: A large percentage of patients with aspirin exacerbated respiratory disease (AERD) report the development of alcohol-induced respiratory reactions, but the true prevalence of respiratory reactions caused by alcoholic beverages in these patients was not known. OBJECTIVE: We sought to evaluate the incidence and characteristics of alcohol-induced respiratory reactions in patients with AERD. METHODS: A questionnaire designed to assess alcohol-induced respiratory symptoms was administered to patients at Brigham and Women's Hospital and Scripps Clinic. At least 50 patients were recruited into each of 4 clinical groups: (1) patients with aspirin challengeeconfirmed AERD, (2) patients with aspirintolerant asthma (ATA), (3) patients with aspirin tolerance and with chronic rhinosinusitis, and (4) healthy controls. Two-tailed Fisher exact tests with Bonferroni corrections were used to compare the prevalence of respiratory symptoms among AERD and other groups, with P £ .017 considered significant. RESULTS: The prevalence of alcohol-induced upper (rhinorrhea and/or nasal congestion) respiratory reactions in patients with AERD was 75% compared with 33% with aspirin-tolerant asthma, 30% with chronic rhinosinusitis, and 14% with healthy controls (P < .001 for all comparisons). The prevalence of alcohol-induced lower (wheezing and/or dyspnea) respiratory reactions in AERD was 51% compared with 20% in aspirintolerant asthma and with 0% in both chronic rhinosinusitis and healthy controls (P < .001 for all comparisons). These reactions were generally not specific to one type of alcohol and often occurred after ingestion of only a few sips of alcohol. CONCLUSION: Alcohol ingestion causes respiratory reactions in the majority of patients with AERD, and clinicians should be aware that these alcohol-induced reactions are significantly more common in AERD than in controls who are aspirin tolerant. Aspirin exacerbated respiratory disease (AERD) is characterized clinically by the triad of asthma, recurrent nasal polyposis, and hypersensitivity to COX-1 inhibitors. 1 This asthma subtype accounts for 5% to 10% of adults with asthma, 2 yet represents a disproportionately high proportion of severe asthma cases 3 and can be difficult to diagnose and treat. Formal aspirin challenges are required for a definitive diagnosis of AERD, 4 in part, because self-reported aspirin sensitivity is not reliably predictive because many patients with asthma do not use nonsteroidal anti-inflammatory drugs regularly and may be unaware of their hypersensitivity to these drugs. 9 Alcohol-induced respiratory reactions have been reported with rates that varied from 20% to 40% in patients with asthma [10] [11] [12] and occasionally in patients with rhinitis 13 and in the general population. 14 However, the majority of our patients with AERD described experiencing respiratory reactions after alcohol ingestion, with a seemingly greater prevalence than that known for other patient groups, and several patients with AERD reported that alcohol had induced frightening lower respiratory symptoms and acute asthma exacerbations. Although an association between aspirin sensitivity and alcohol-induced reactions in patients with asthma has been suggested, 10, 11, 15 these reactions have never been characterized in a well-phenotyped group of patients with aspirin challengee confirmed AERD.
In addition, we found no published data regarding the characteristics of alcohol-induced respiratory reactions in patients with AERD. To address these issues and to explore the potential mechanisms that underlie alcohol-induced reactions, we designed a questionnaire to investigate the incidence and frequency of reactions, and to examine details, including time to onset of reactions, the amount of alcohol required to induce reactions, and the type of alcohol most likely to cause reactions. We offered participation in this multicentered questionnaire-based study to patients with AERD and confirmed aspirin challenge, and to 3 clinically defined control groups: patients with aspirin-tolerant asthma (ATA), chronic rhinosinusitis (CRS), and healthy controls. Our findings show that patients with AERD report a strikingly high prevalence of both upper and lower respiratory reactions induced by alcohol; this observation furthers the clinical characterization of AERD and may suggest its diagnosis.
METHODS

Patients and human subject characterization
Study participants between the ages of 21 and 75 years were recruited from the Brigham and Women's Hospital Allergy and Asthma and Otolaryngology Clinics, and from the Scripps Clinic's Allergy and Asthma Clinic. The subjects completed surveys in the form of printed questionnaires or through REDCap (Vanderbilt University, Nashville, Tenn), an online data-gathering and analysis tool; all the participants from the Scripps Clinic completed printed questionnaires. Due to limitations in the questionnaire protocol as approved at the Scripps Clinic, demographic information and clinical information from the medical records were only collected from subjects recruited at the Brigham and Women's Hospital. Recruitment at both centers began in April 2012 and concluded in May 2013.
The participants were allocated into 4 clinical groups: (1) patients with AERD whose diagnosis was confirmed after a respiratory reaction was documented during a supervised challenge to aspirin, (2) patients with ATA, (3) patients without asthma and with CRS, and (4) healthy controls. Patients who had never consumed alcohol and those diagnosed with cystic fibrosis were excluded from participation. All subjects with ATA had physician-diagnosed asthma and had taken a COX-1 inhibitor in the past 6 months without adverse reaction. Subjects with CRS were physician-diagnosed based on published guideline criteria, 16 had taken a COX-1 inhibitor in the past 6 months without adverse reaction, and had no history of asthma in adulthood. Subjects were excluded from the healthy control group if they had a history of asthma, rhinitis, AERD, or sensitivity to any COX-1 inhibitor. The human subjects institutional review boards of the Brigham and Women's Hospital (protocol 2012-P-000175) and the Scripps Clinic (protocol IRB-12-5856) approved the study, and all the subjects provided written consent in accordance with the Declaration of Helsinki.
Questionnaire and study design
The complete questionnaire is available in Figure E1 (in this article's Online Repository at www.jaci-inpractice.org). The number of questions was limited to 18 to avoid bias from responder fatigue. The questionnaire confirmed the presence or absence of physician-diagnosed asthma, nasal polyposis, CRS, and AERD. A history of respiratory reactions to alcohol was evaluated with the question, "has drinking alcohol ever triggered any of the following symptoms? (check all that apply)," with the following possible answers: "stuffy nose and/or nasal congestion, runny nose, shortness of breath, wheezing, none of the above." Upper respiratory symptoms were defined as positive answers to either of the first 2 questions, and lower respiratory symptoms were defined as positive answers to either of the latter two. Respondents who checked any of the above respiratory symptoms were then asked several questions to detail their alcohol-induced reactions in regard to time to onset, frequency, specificity to alcohol type, and quantity of alcohol required to provoke reactions, and whether they had cut down their alcohol consumption due to the development of respiratory reactions. The subjects with AERD who had been desensitized to aspirin and continued with daily high-dose aspirin treatment were asked whether or not aspirin therapy blunted alcohol-induced reactions. Susceptibility to common environmental irritants, a selfassessment of their sense of smell, use of intranasal corticosteroids, and number of lifetime nasal polypectomies were inquired as measures of baseline respiratory disease. For participants from Brigham and Women's Hospital, asthma severity of the subjects with AERD was compared with that of the subjects with ATA by using the Asthma Control Test (ACT; GlaxoSmithKline, Brentford, UK) scores (range, 5-25; with >19 indicating wellcontrolled asthma) and FEV 1 values from office spirometry.
Statistical analysis
A 2-tailed Fisher exact test with Bonferroni correction was used to compare the prevalence of respiratory symptoms between AERD and other groups, with P .0125 considered significant. This statistical tool also was used to compare sex and racial and/ or ethnic compositions of the study groups, the prevalence in reaction rates in men versus women within each group, alcohol types that provoked respiratory reactions most forcefully, the quantity of alcohol required to provoke reactions, time to onset, frequency of reactions, and inter-and within-group comparisons between reactions to alcohol and reactions to other exposures. An unpaired t test compared the percentage predicted FEV 1 and ACT scores between subjects with AERD and those with ATA, with P .05 considered significant.
RESULTS
Demographics and characteristics of respiratory disease
A total of 213 study participants were recruited; their demographic data are summarized in Table I . There were no statistical differences in racial and/or ethnic backgrounds or age of patients in each group. Consistent with previous reports, 3 the AERD patient group had a slight female predominance. There was no significant difference in rates of alcohol-induced reactions in female versus male patients in any clinical group. Asthma severity in Brigham and Women's Hospital's study subjects, compared by using baseline percentage predicted FEV 1 and ACT scores whenever available from the medical record, was not statistically different between patients with ATA and those with AERD. The percentage of subjects diagnosed with nasal polyps (NP) also is reported, and, as expected, nearly all the patients with AERD had NPs.
Prevalence of alcohol-induced respiratory symptoms
The prevalence of upper and lower alcohol-induced respiratory reactions reported by each patient group is summarized in Figure 1 . To address the concern that nasal polyposis may confound differences of reaction rates among groups, an additional clinical subgroup was defined to include all respondents who were aspirin tolerant and with NPs, derived from the ATA and CRS groups; no healthy controls had NPs. Upper respiratory reactions to alcoholic beverages were reported by 75% of respondents with AERD, in contrast to 33% of respondents with ATA, 30% of respondents with CRS, 40% of respondents who were aspirin tolerant and with NPs, and 14% of healthy controls (P < .001 for the above 4 comparisons, Figure 1, A) . Lower respiratory reactions also were significantly more common in patients with AERD (51%) versus patients with ATA (20%) and patients with aspirin tolerance and with NPs (10%); no subject without asthma (CRS and healthy controls) reported lower respiratory reactions to alcohol (P < .001 for the above 4 comparisons, Figure 1, B) . Respiratory reactions of either type, upper and/or lower, were more frequently reported by patients with AERD (83%) than by those with ATA (43%), CRS (30%), patients who were aspirin tolerant and with NPs (43%), or healthy controls (14%) (P < .001) (Figure 1, C) . These reported reaction rates were not statistically different within any patient group between those subjects surveyed at the Scripps Clinic and those surveyed at the Brigham and Women's Hospital. Of respondents who reported alcohol-induced respiratory reactions, 73% of those with AERD reduced alcohol consumption or quit after developing these reactions, and 57% of patients with asthma and with aspirin tolerance did so. This difference was not statistically significant (P ¼ .18).
Characterization of respiratory reactions to alcoholic beverages
Participants who reported alcohol-induced respiratory reactions were asked to identify which type of alcohol elicited reactions most forcefully. Responses were similar across patient groups (Figure 2 ). Although many patients identified red wine as the most forceful trigger, no single alcohol type was determined to be the main culprit, and more than one-third of the subjects with AERD and ATA reported that all alcohol types were equivalent triggers for respiratory reactions. The quantity of alcohol needed to elicit respiratory reactions was similar between AERD and ATA, and was 3 glasses for almost all participants; the majority of patients with AERD (51%) reported that "a few sips" would elicit their reactions (Table II) . The majority of respondents with both AERD and ATA developed their reactions 1 hour of alcohol intake (84% and 78%, respectively) (Table III) and reported doing so "more than half the time" or "all the time" they drank alcohol in 65% and 61% of cases, respectively (data not shown). In addition, of the respondents with AERD who had begun high-dose daily aspirin therapy and had re-tried drinking alcohol after starting aspirin, 63% reported an improvement in alcohol-induced respiratory reactions since starting this therapy (data not shown). To assess whether reactivity to alcohol was associated with reactivity to other types of exposures and, therefore, associated with general respiratory sensitivity, the participants were asked about respiratory reactions to cold or hot air, use of toothpaste, beef consumption, cold or hot beverages, or "any." The prevalence of reactions to these exposures was similar across all 4 patient groups and also similar for all study groups when patients were subcategorized into alcohol responders and nonresponders, without statistically significant differences noted (data not shown). Relationship between the severity of aspirin-induced reactions and alcohol-induced reactions in patients with AERD
We sought to determine whether a relationship existed between the severity of aspirin-induced reactions and the severity of alcohol-induced reactions in patients with AERD. Nasal symptoms that involved only the upper respiratory tract are generally considered to be mild and less intense than potentially lifethreatening lower respiratory symptoms of wheezing and shortness of breath, and, therefore, patients who developed lower respiratory symptoms were defined as having "severe" reactions. The 23 patients with AERD and for whom clinical data from their aspirin challenge were available were subdivided into those who developed only upper respiratory reactions (n ¼ 10) and those who developed lower respiratory reactions (including a fall of 15% in FEV 1 during aspirin challenge [n ¼ 13]); their likelihood of reacting to alcohol was compared. The patients who developed only upper respiratory reactions or no reactions to alcohol were statistically significantly more likely to have developed only upper respiratory reactions to aspirin, and patients who developed lower respiratory reactions to alcohol were statistically significantly more likely to have developed lower respiratory reactions during aspirin challenge (Table IV) . The odds of developing a lower respiratory reaction to aspirin was 8.2-fold greater (95% CI, 1.2-59.0) for subjects with AERD who had developed lower respiratory reactions to alcohol compared with those who had developed upper respiratory only or no reactions to alcohol.
DISCUSSION
Previous studies have shown that respiratory reactions may result from alcohol consumption, especially in persons with asthma. In a cross-sectional study in 2008 with 4066 participants, Linneberg et al 14 found the rates of alcohol-induced upper and lower respiratory reactions to be 7.6% and 3.2%, respectively. These reactions were more prevalent in persons with asthma, with 17.5% reporting upper and 12.9% reporting lower respiratory reactions. Other studies reported similar rates of alcohol-induced respiratory reactions in persons with asthma, which ranged from 21% to 40%. [10] [11] [12] [13] However, less was known about alcohol-induced respiratory reactions in patients with AERD. The only previous study that investigated both alcohol-induced reactions and AERD was a survey by Vally et al 10 of 366 subjects with asthma, of whom 11% selfreported aspirin-induced asthma. This study found that 33% of the subjects with asthma reported alcohol-induced respiratory exacerbations and noted increased rates in patients with selfreported aspirin-induced asthma because the odds ratio for alcohol-induced respiratory reactions was 2.98 for this subgroup of subjects with asthma. To more specifically examine this phenomenon, we sought to investigate the rates and characteristics of alcohol-induced reactions in patients who were well-phenotyped and with AERD and in controls who were aspirin tolerant.
A large portion of the subjects with asthma who completed our survey reported the onset of respiratory reactions upon alcohol ingestion. Our finding, that 43% of patients with ATA developed upper and/or lower alcohol-induced respiratory reactions was similar to rates described for subjects with asthma in other studies.
10,12 However, we found that 83% of patients with AERD developed alcohol-induced respiratory reactions, which is strikingly higher than the rates found in any other clinical group and is in keeping with the anecdotal evidence from our clinic patients. Analysis of our data did not suggest that this high reaction rate was due to differences in severity of baseline pulmonary disease because there was no difference in asthma severity or control between patients with AERD and ATA as measured by the ACT score and FEV 1 . These high reaction rates also were not explained by the presence of NPs because the reaction rates in patients with aspirin tolerance and with NPs was approximately half that of patients with AERD and with NPs. There was a slight female predominance in our AERD FIGURE 1. Prevalence of alcohol-induced respiratory symptoms. Rates of alcohol-induced (A) upper, (B) lower, and (C) upper and/or lower respiratory reactions among survey respondents with AERD, ATA, CRS, aspirin-tolerant subjects with NPs, and healthy controls. *P < .001 for all 4 rates compared with the AERD group in A-C.
J ALLERGY CLIN IMMUNOL PRACT VOLUME 2, NUMBER 2 population, which paralleled the findings of previous groups, 3 although there was no sex-specific difference in alcohol-induced reaction rates in either patients with aspirin tolerance or those with AERD. Because respiratory reactions began for most respondents within minutes of drinking even very small amounts of alcohol, alcohol intoxication is also unlikely to be the causative mechanism of these reactions. However, the <30-minute timeto-onset of reaction may correlate with peak blood alcohol levels because peak alcohol levels are often achieved within 30 minutes of ingestion. 17 Sulfite hypersensitivity also exists in some patients with asthma 18, 19 and, although one-third of our respondents with AERD reported that red wine was the alcohol type that caused the most forceful respiratory reactions, most patients found that all alcohols incited reactions, even those with little to no sulfites. In addition, studies that compared bronchoconstriction induced by wine with high versus low sulfite content have not found any difference between the two, [20] [21] [22] which suggests that alcohol itself, and not an additive, is the culprit for these reactions. Sensitivity to alcohol is common in Asian populations due to a polymorphism in acetaldehyde dehydrogenase, and patients classically present with facial flushing and occasionally respiratory symptoms. 23 In Western populations; however, this polymorphism is infrequent and thus unlikely to be the mechanism that underlies the reactions described by our patients with AERD.
One consistent finding in AERD is that patients have elevated cysteinyl leukotrienes (LT) levels at baseline, reflected by the detection of the end metabolite LTE 4 in urine, which increases further during reactions to aspirin. 24 Cysteinyl LTs are powerful bronchoconstrictors and the main effectors of aspirin-induced reactions, but neither the cellular source of cysteinyl LTs nor the mechanisms of aspirin-induced increase are known. The mechanisms that underlie the alcohol-induced respiratory reactions in patients with AERD also are unknown, but, when considering the dominant role that cysteinyl LTs play in AERD pathogenesis, we suspect that a similar LT-dependent mechanism may underlie their alcohol-induced respiratory reactions. Moreover, the baseline level of urinary LTE 4 is currently the only biomarker available to clinicians for predicting the severity of aspirininduced reactions in patients with AERD. 25 However, in this study, we found that the severity of aspirin-induced reactions (observed in the clinic during aspirin challenges) positively correlated with the severity of alcohol-induced reactions (selfreported by the survey respondents). Given that urinary LTE 4 measurements are mostly limited to research centers, this new finding may aid clinicians in predicting the severity of reactions during aspirin challenges and in counseling patients about consequences of alcohol consumption.
Indeed, excessive ethanol consumption by healthy individuals has been shown to increase urinary LTE 4 excretion, which presumably reflects elevated systemic cysteinyl LT levels due to ethanol-induced inhibition of LT catabolism. 26 Although these alcohol-induced urinary LTE 4 elevations did not cause reactions in healthy individuals, patients with asthma are known to be FIGURE 2. Alcohol types that provoke reactions most forcefully. Among participants who reported alcohol-induced respiratory reactions, the types of alcohol they identified as eliciting reactions most forcefully are shown. Significantly more patients with AERD (39%) identified red wine as the most forceful trigger than did patients with CRS (7%) (P ¼ .02). No other comparisons were significantly different across patient groups. 200-fold more sensitive to LTE 4 -induced bronchoconstriction than are persons without asthma, 27 and patients with AERD are 16-fold more sensitive to bronchoconstriction by LTE 4 than patients with asthma who are aspirin tolerant. 28 It is suspected that this hyperresponsiveness to LTE 4 in AERD is due to overexpression of a yet undiscovered LTE 4 -specific receptor, but, to date, no such receptor has been reported. Interestingly, 63% of respondents with AERD on high-dose daily aspirin therapy who had retried drinking alcohol after starting aspirin reported an improvement in alcohol-induced respiratory reactions, which suggests that high-dose aspirin therapy may attenuate alcohol hyperresponsiveness in patients with AERD.
This study has several limitations, principally those inherent in survey research and its liability to patient recall and response bias. In addition, due to the relatively small population of subjects with AERD available for study, our questionnaire was not able to be formally validated. Therefore, it was subjected to screening by our multiple authors for re-test reliability and linguistic validity before institutional review board submission and administration to study participants, and was based in part on previously published questionnaires. [10] [11] [12] [13] [14] In addition, our survey queried susceptibility to environmental exposures as a measure of interpretability and specificity, and we found similar reaction rates to environmental exposures among study participants (excluding healthy controls), which suggests that our survey questions on respiratory reactions to alcohol were correctly interpreted by respondents and that respiratory reactions to alcohol are specific. For future studies, a doubleblind, placebo-controlled alcohol challenge study would be optimal to circumvent our study's limitations and clarify the mechanisms that underlie our findings.
In this study, we thoroughly examined the effects of alcoholic drinks on the development of respiratory reactions in patients with AERD and found that alcoholic beverages are common and occasionally dangerous triggers for respiratory reactions in these patients. This finding may aid clinicians in the suspicion of AERD and suggests that clinicians should warn their patients with AERD about the potential for alcohol-induced respiratory reactions. J ALLERGY CLIN IMMUNOL PRACT VOLUME 2, NUMBER 2
